Dietary immunostimulants influence specific immune response and resistance of healthy and immunocompromised Asian catfish Clarias batrachus to Aeromonas hydrophila infection.
In order to determine the efficacy and immunoreversal effect of the 4 dietary immunomodulators, viz. lactoferrin, beta-1,3 glucan, levamisole and vitamin C, on disease resistance of a commercially important catfish, Clarias batrachus, fish were fed diets supplemented with various levels of these substances in 2 subgroups, healthy and immunocompromised, during a 30 d trial. An artificial immunosuppressive state was induced by giving 3 intraperitoneal (i.p.) injections of cyclophosphamide (CYP) at a dose level of 200 mg kg(-1) body weight at 1 wk intervals in the immunocompromised vaccinated subgroup and 3 consecutive injections 3 d before challenge in the immunocompromised non-vaccinated subgroup. On the first day of the experiment, the fish were vaccinated against a formalin-killed Aeromonas hydrophila bacterin. After 30 d, antibody titre (as measured through bacterial agglutination titre) and disease resistance against A. hydrophila were determined. The results demonstrate that all 4 immunomodulators were capable of significantly (p < 0.05) enhancing the specific immune response; this was evident through raised antibody titre and protection against A. hydrophila in both healthy and immunocompromised vaccinated subgroups compared to their respective controls. Similarly, all 4 substances significantly raised the survival rates in immunocompromised and healthy non-vaccinated fish. Thus, these substances were capable of reducing the immunosuppression induced by CYP injections in both vaccinated and non-vaccinated fish compared to their respective controls. Among the 4 substances studied, beta-1,3 glucan was found to be the most effective immunomodulator, followed by levamisole, lactoferrin and vitamin C in Asian catfish. Therefore, the results support the introduction of these substances into the diet of fish grown in farms under immunosuppressive/stressful conditions in order to enhance protection against infection and offer economic benefits.
Kumari
Jaya
J
Central Institute of Freshwater Aquaculture, Kausalyaganga, Bhubaneswar 751 002, India.
Sahoo
P K
PK
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D016980:Aeromonas hydrophila / Q000276:immunology*; D000818:Animals; D000906:Antibodies / Q000097:blood; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000494:pharmacology; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology; D002397:Catfishes / Q000276:immunology* / Q000382:microbiology; D003520:Cyclophosphamide / Q000494:pharmacology; D019587:Dietary Supplements; D005393:Fish Diseases / Q000276:immunology* / Q000382:microbiology; D016905:Gram-Negative Bacterial Infections / Q000276:immunology / Q000662:veterinary*; D007113:Immunity, Innate / Q000187:drug effects / Q000276:immunology; D016867:Immunocompromised Host / Q000187:drug effects; D007781:Lactoferrin / Q000008:administration & dosage / Q000494:pharmacology; D007978:Levamisole / Q000008:administration & dosage / Q000494:pharmacology; D016019:Survival Analysis; D013997:Time Factors; D047071:beta-Glucans / Q000008:administration & dosage / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D000906:Antibodies; D001428:Bacterial Vaccines; D047071:beta-Glucans; D007978:Levamisole; D003520:Cyclophosphamide; C033363:beta-1,3-glucan; D007781:Lactoferrin; D001205:Ascorbic Acid